- Former radio personality Radene Marie Cook rues 'fail first' treatment plans for chronic pain
- Ensuring access to chronic pain medications
- Mylan Specialty announces winners of anaphylaxis awareness campaign
- Mylan launches generic version of Detrol LA
- ROUNDTABLE: Improving patient outcomes, controlling costs with OTCs
BASKING RIDGE, N.J. — A company that makes an emergency treatment for severe allergic reactions is marking the 15th annual Food Allergy Awareness Week.
Mylan Specialty, a division of drug maker Mylan, said it would support various initiatives to raise awareness of life-threatening food allergies during the special week, which started Sunday and ends Saturday. Mylan Specialty is the maker of EpiPen (epinephrine), used to treat anaphylaxis, a severe allergic reaction that can occur quickly and without warning.
"Life-threatening allergies are an important and growing public health issue, and we are proud to stand with advocacy partners to shine the spotlight on the need for awareness and preparedness during Food Allergy Awareness Week," Mylan CEO Heather Bresch said. "We are especially pleased by the increasing efforts at the federal and state level to encourage schools to develop and implement plans that help protect students with life-threatening allergies, including having immediate access to epinephrine."